Anti-VEGF agents can enhance chemosensitivity due to the dual role of VEGF in the tumor microenvironment: (1) promoting aberrant and undifferentiated tumor angiogenesis and (2) exerting immunosuppressive effects on tumor cells [3]. This evidence concerns the gene VEGFA and neoplasm.